openPR Logo
Press release

Cardioplegia Delivery Systems Market to Perceive Substantial Growth During 2017 - 2025

05-28-2018 01:24 PM CET | Health & Medicine

Press release from: Persistence Market Research

Cardioplegia Delivery Systems Market to Perceive Substantial

Cardioplegia combines the Greek word “cardio” meaning “heart” and “plegia” mean “paralysis”, this mean cardioplegia is a process that involves stopping or arresting the heart. Cardioplegia delivery system is used to stop the blood supply or control the blood supply to the heart during the surgical procedure. Cardioplegia procedure is used to bring the asystole of the heart. Cardioplegia delivery system the myocardium or heart muscles from the damage during surgical procedures. Cardioplegia induces heart isolation and heart does not receive any blood supply or oxygen for metabolism. Metabolism get lowered during cardioplegia, thus preventing cell death during the period of cardiac surgery.

Request for Table of Contents @ https://www.persistencemarketresearch.com/toc/19135

Cardioplegia delivery system market is expected to be driven the increasing prevalence of disease or conditions related to heart. Increasing number of cardiac surgeries such as, open heart surgery are driving the market of cardioplegia delivery system. Improving healthcare infrastructure and focus on providing better treatment option is also driving the market of cardioplegia delivery system. Increasing focus on medical insurance and coverage is also expected to drive market of cardioplegia delivery system. High cost of the surgical procedure is expected to be restraining factor for the growth of cardioplegia delivery system market in low- and middle-income countries.

The global cardioplegia delivery system market can be segmented on the basis of product type, end user and region.

On the basis of product type, the global cardioplegia delivery system market can be segmented as:

Crystalloid Solution Delivery System
Blood Cardioplegia Delivery System
Microplegia Delivery System

On the basis of end user, the global cardioplegia delivery system market can be segmented as:

Hospitals
Cardiac Centers
Ambulatory Surgical Centers

Cardiac delivery system market is expected to show a significant growth over the forecast period. Increasing incidence of cardiac problem is expected to increase the use of cardioplegia delivery system market. As, rising cases of cardiac or heart related problems are leading to the increased surgical procedures. As during surgical procedure, blood flow interfere with vision of surgeon and to overcome this cardioplegia delivery system is used to control flow of blood to heart. Blood cardioplegia delivery system product segment is dominating the market of cardioplegia delivery system as it involve continuous blood flow to the heart but with a control on the quality of supply. Crystalloid delivery system is expected to be fastest growing product segment due to the increasing focus on minimizing the blood supply or completely stop the supply of blood the heart during surgical procedure and improve the efficiency of surgical procedure with minimum damage to heart cells.

The global cardioplegia delivery system market can be segmented into regions: North America, Latin America, Europe, Asia Pacific and Middle East & Africa. North America dominates the global cardioplegia delivery system market and is expected to continue to dominate over the forecast period. Increasing prevalence of heart related disease and rising number of geriatric population in the region is expected to be growth driving factor for cardioplegia delivery system market in region. Other factors include, better reimbursement policies and advanced healthcare infrastructure. Europe and Asia Pacific region are expected to be among fastest growing cardioplegia delivery system market. Larger pool of potential patients and high unmet need are expected to drive the market of cardioplegia delivery system in Asia Pacific region.

Request a Sample Brochure of the Report @ https://www.persistencemarketresearch.com/samples/19135

Some of the market participants in the global cardioplegia delivery system are, Medtronic Public Limited Company, Sidd Life Sciences Private Limited, LivaNova plc., Nipro Medical Corporation, Creganna Medical, Weigao Group, Biomed Surgicals, Quest Medical, Inc., Avishkar International Pvt. Ltd., Kirloskar Technologies and Lifeline Service Pvt. Ltd.

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us

Persistence Market Research

305 Broadway

7th Floor, New York City,

NY 10007, United States,

Telephone - +1-646-568-7751

USA – Canada Toll Free: 800-961-0353

Email: sales@persistencemarketresearch.com

Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cardioplegia Delivery Systems Market to Perceive Substantial Growth During 2017 - 2025 here

News-ID: 1063778 • Views:

More Releases from Persistence Market Research

Vaginitis Treatment Drug Market Growth Accelerated by Rising Awareness of Women's Health - Persistence Market Research
Vaginitis Treatment Drug Market Growth Accelerated by Rising Awareness of Women' …
The global vaginitis treatment drug market is experiencing consistent growth, reflecting the growing global emphasis on women's reproductive health and wellness. Valued at approximately US$3.3 billion in 2024, the market is expected to reach US$5.3 billion by 2031, registering a compound annual growth rate (CAGR) of 5.0% during the forecast period (2024-2031). This steady expansion is attributed to multiple factors including the rising prevalence of bacterial vaginosis (BV), yeast infections,
Assembly Line Solutions Market Poised for 7.3% CAGR Growth Through 2032, Says Persistence Market Research
Assembly Line Solutions Market Poised for 7.3% CAGR Growth Through 2032, Says Pe …
The global Assembly Line Solutions Market is witnessing a profound transformation, driven by the accelerating adoption of automation and smart manufacturing technologies across industrial sectors. The market, valued at US$294.5 billion in 2025, is projected to reach approximately US$483.5 billion by 2032, expanding at a robust CAGR of 7.3% over the forecast period (2025-2032). This growth reflects the rising demand for intelligent manufacturing systems that can enhance productivity, minimize downtime,
Retinal Biologics Market to Reach New Heights with Rising AMD Cases, Says Persistence Market Research
Retinal Biologics Market to Reach New Heights with Rising AMD Cases, Says Persis …
The global retinal biologics market is witnessing dynamic transformation, driven by an aging population, rising prevalence of retinal diseases, and advances in biotechnology. Retinal biologics are therapeutic agents derived from living organisms that target the underlying molecular mechanisms responsible for retinal disorders. These biologics, such as Eylea (aflibercept), Lucentis (ranibizumab), and Vabysmo (faricimab-svoa), have revolutionized the management of conditions like age-related macular degeneration (AMD), diabetic retinopathy, and diabetic macular edema
Neuroendocrine Carcinoma Treatment Market Growth Driven by Novel Therapies, Says Persistence Market Research
Neuroendocrine Carcinoma Treatment Market Growth Driven by Novel Therapies, Says …
Neuroendocrine carcinoma (NEC) is a rare and complex cancer that arises from neuroendocrine cells, which are spread across various organs in the body, including the gastrointestinal tract, pancreas, and lungs. As a result, the treatment landscape for NEC is multifaceted, involving a range of therapeutic modalities including surgery, chemotherapy, targeted therapy, immunotherapy, and radioligand therapy. The global market for neuroendocrine carcinoma treatment has seen significant growth over the past decade,

All 5 Releases


More Releases for Cardioplegia

Disposable Cardioplegia Infuser Market Future Business Scope Analysis Report, Ma …
" The disposable cardioplegia infuser market is valued at approximately $450 million in 2024, with expectations to reach $1 billion by 2034. This signifies a robust growth trajectory driven by advancements in cardiac surgery and increasing adoption of minimally invasive procedures. The projected Compound Annual Growth Rate (CAGR) from 2025 to 2034 is estimated at around 8.5%, fueled by rising demand for disposable devices that enhance surgical efficiency and reduce
Cold Cardioplegia Infusion Device Market Outlook and Future Projections for 2030
The cold cardioplegia infusion device market represents a dynamic and continually evolving landscape, shaped by changing consumer demands and technological advancements. In this comprehensive report, we provide an in-depth exploration of the market, designed for a wide range of stakeholders including manufacturers, suppliers, distributors, and investors. Our goal is to equip industry participants with essential insights that enable informed decision-making in an ever-changing market environment. This analysis not only examines
Cardioplegia Delivery Systems Market 2020 Key Strategies, Historical Analysis, A …
This versatile composition of research derivatives pertaining to diverse concurrent developments in the global Cardioplegia Delivery Systems market is poised to induce forward-looking perspectives favoring unfaltering growth stance. This elaborate research report on global Cardioplegia Delivery Systems market in an all-inclusive research study of the various developments in the market and their concurrent implications on crucial elements such as Growth Propellants, Upcoming Trends, Ongoing Developments Ample Opportunities as well as the
Global Cardioplegia Delivery Systems Market Business Opportunities 2026 - Top Co …
Dataintelo offers a latest published report on Global Cardioplegia Delivery Systems Market industry analysis and forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains XX pages which highly exhibits on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability. Cardioplegia Delivery Systems Market research report delivers a close watch on leading competitors with strategic analysis,
Global Cardioplegia Delivery Systems Market Size, Competitive Landscape, Regiona …
According to HJ Research's latest research report, the global Cardioplegia Delivery Systems market is estimated to be valued at XX Million US$ in 2019 and is projected to reach XX Million US$ by 2026, expanding at a CAGR of XX% during the forecast period. The report on Cardioplegia Delivery Systems market provides qualitative as well as quantitative analysis in terms of market dynamics, competition scenarios, opportunity analysis, market growth, industrial
Cardioplegia Delivery Set Market to Witness Robust Expansion by 2025
Market Research Report Store offers a latest published report on Cardioplegia Delivery Set Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Cardioplegia Delivery Set players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. Click to view the full report TOC, figure